StockData
GNTANasdaqBiological Products, (No Diagnostic Substances)

Genenta Science S.p.A.

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 1, 2026
$0.66−0.02 (-2.40%)

Close on Oct 19, 2026

Genenta Science S.p.A. revenue by segment

AnnualQuarterlyTTM

No segment breakdown reported

Genenta Science S.p.A. does not break out revenue by segment, region or product in the tagged data of its filings for this period type.